Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Impact of no residual versus residual disease after hysterectomy for stage 1 cervical cancer on recurrence
Background: Histopathological risk factors for recurrence of cervical cancer following hysterectomy for stage I disease are well established. The impact of residual disease after LEEP in patients undergoing hysterectomy for stage 1 cervical cancer on recurrence has not been extensively studied. Desi...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English English |
| Published: |
Department of Obstetrics and Gynaecology
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867614374276890624 |
|---|---|
| access_status_str | Open Access |
| author | Ntunja, Sive |
| author2 | Mbatani, Nomonde |
| author_browse | Mbatani, Nomonde Ntunja, Sive |
| author_facet | Mbatani, Nomonde Ntunja, Sive |
| author_sort | Ntunja, Sive |
| collection | Thesis |
| description | Background: Histopathological risk factors for recurrence of cervical cancer following hysterectomy for stage I disease are well established. The impact of residual disease after LEEP in patients undergoing hysterectomy for stage 1 cervical cancer on recurrence has not been extensively studied. Design and Methods: Records of all patients who underwent hysterectomy for stage I cervical cancer from 1st January 2008 to 31st December 2017 were reviewed. The follow-up period was at least 60 months or until death. Data collected included demographic information, histopathological risk factors, residual disease status on hysterectomy specimen, treatment modalities and recurrence rates. Results: We analysed 147 patients: 55 stage 1A1, 11 stage 1A2, 80 stage 1B1 and 1 with stage 1B2. Median age was 47 (27 – 76) years. All patients had a cervical excision procedure (LEEP OR CKC) for histological diagnosis, followed by simple hysterectomy (29.6%), simple hysterectomy with lymphadenectomy (12.3%) or radical hysterectomy (58.2%). The prevalence of residual disease on hysterectomy specimen was 56.5%, versus no residual disease (43.5%). The overall recurrence rate was 9.5%. Thirty patients received adjuvant radiotherapy, of these, 29 had residual disease, with 6.2% of them developing disease recurrence. The overall survival (OS) and disease-free interval (DFI) were 96.6% and 91.6% respectively. Conclusion: This study found a correlation between presence of residual disease and known histological risk factors, that is size of the lesion and depth of stromal invasion. However, there was no strong correlation between residual disease and lymphovascular space invasion in this study. All patients that had recurrence had residual disease. When excluding those with lymph node metastasis, there were no recurrences in the group with no residual disease. |
| format | Thesis |
| id | oai:open.uct.ac.za:11427/42638 |
| institution | University of Cape Town (South Africa) |
| language | English eng |
| last_indexed | 2026-06-10T12:51:01.699Z |
| license_str | Not specified — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository |
| publishDate | 2026 |
| publishDateRange | 2026 |
| publishDateSort | 2026 |
| publisher | Department of Obstetrics and Gynaecology |
| publisherStr | Department of Obstetrics and Gynaecology |
| record_format | dspace |
| source_str | UCTD — University of Cape Town Open Access Repository |
| spelling | oai:open.uct.ac.za:11427/42638 Impact of no residual versus residual disease after hysterectomy for stage 1 cervical cancer on recurrence Ntunja, Sive Mbatani, Nomonde Fakie, Nazia cervical cancer, residual disease, histopathological risk factors, cervical excision procedure, cervical cancer recurrence Background: Histopathological risk factors for recurrence of cervical cancer following hysterectomy for stage I disease are well established. The impact of residual disease after LEEP in patients undergoing hysterectomy for stage 1 cervical cancer on recurrence has not been extensively studied. Design and Methods: Records of all patients who underwent hysterectomy for stage I cervical cancer from 1st January 2008 to 31st December 2017 were reviewed. The follow-up period was at least 60 months or until death. Data collected included demographic information, histopathological risk factors, residual disease status on hysterectomy specimen, treatment modalities and recurrence rates. Results: We analysed 147 patients: 55 stage 1A1, 11 stage 1A2, 80 stage 1B1 and 1 with stage 1B2. Median age was 47 (27 – 76) years. All patients had a cervical excision procedure (LEEP OR CKC) for histological diagnosis, followed by simple hysterectomy (29.6%), simple hysterectomy with lymphadenectomy (12.3%) or radical hysterectomy (58.2%). The prevalence of residual disease on hysterectomy specimen was 56.5%, versus no residual disease (43.5%). The overall recurrence rate was 9.5%. Thirty patients received adjuvant radiotherapy, of these, 29 had residual disease, with 6.2% of them developing disease recurrence. The overall survival (OS) and disease-free interval (DFI) were 96.6% and 91.6% respectively. Conclusion: This study found a correlation between presence of residual disease and known histological risk factors, that is size of the lesion and depth of stromal invasion. However, there was no strong correlation between residual disease and lymphovascular space invasion in this study. All patients that had recurrence had residual disease. When excluding those with lymph node metastasis, there were no recurrences in the group with no residual disease. 2026-01-21T11:08:53Z 2026-01-21T11:08:53Z 2025 2026-01-21T11:02:00Z Thesis / Dissertation Masters MMed http://hdl.handle.net/11427/42638 en eng application/pdf Department of Obstetrics and Gynaecology Faculty of Health Sciences University of Cape Town |
| spellingShingle | cervical cancer, residual disease, histopathological risk factors, cervical excision procedure, cervical cancer recurrence Ntunja, Sive Impact of no residual versus residual disease after hysterectomy for stage 1 cervical cancer on recurrence |
| thesis_degree_str | Master's |
| title | Impact of no residual versus residual disease after hysterectomy for stage 1 cervical cancer on recurrence |
| title_full | Impact of no residual versus residual disease after hysterectomy for stage 1 cervical cancer on recurrence |
| title_fullStr | Impact of no residual versus residual disease after hysterectomy for stage 1 cervical cancer on recurrence |
| title_full_unstemmed | Impact of no residual versus residual disease after hysterectomy for stage 1 cervical cancer on recurrence |
| title_short | Impact of no residual versus residual disease after hysterectomy for stage 1 cervical cancer on recurrence |
| title_sort | impact of no residual versus residual disease after hysterectomy for stage 1 cervical cancer on recurrence |
| topic | cervical cancer, residual disease, histopathological risk factors, cervical excision procedure, cervical cancer recurrence |
| url | http://hdl.handle.net/11427/42638 |
| work_keys_str_mv | AT ntunjasive impactofnoresidualversusresidualdiseaseafterhysterectomyforstage1cervicalcanceronrecurrence |